To evaluate whether TNFR2 upregulation on human BRAFV600E+ melanomas is directly mediated by MAPKi, we treated the TNFR2-negative SK-Mel-28 cell line with BRAFi or MEKi. The gene discussed is TNFRSF1B; the disease is melanoma.